Concepedia

Author

Nagahiro Ochiai

Taisho Pharmaceutical (Japan)ORCID

Also Known As

Nagahiro Ochiai

9

Publications

87

Citations

6

H-Index

12

Concepts

All Affiliations

Taisho Pharmaceutical (Japan)
NO

About

Nagahiro Ochiai is an author at Taisho Pharmaceutical (Japan) specializing in regenerative medicine, tissue engineering, and stem cell therapies.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

1

1

11

2

Medicine

1

1

11

3

Cell Biology

1

1

11

4

Regenerative Medicine

1

1

11

5

Developmental Biology

1

1

11

Nagahiro Ochiai

×

3

Publications

58

Citations

3

H-Index

YearCitations

Murine osteoclasts secrete serine protease HtrA1 capable of degrading osteoprotegerin in the bone microenvironment

Nagahiro Ochiai, Yutaka Nakachi, Tomotaka Yokoo,

Communications Biology

2019

25

TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver

Sota Kato, Nagahiro Ochiai, Hiroki Takano,

Journal of Pharmacology and Experimental Therapeutics

2019

22

Basic fibroblast growth factor promotes meniscus regeneration through the cultivation of synovial mesenchymal stem cells via the CXCL6–CXCR2 pathway

Atsushi Goshima, Yuki Etani, Makoto Hirao,

Osteoarthritis and Cartilage

2023

11

Page 1